WHO’s Africa Hub Starts Work on mRNA Tuberculosis Vaccine
- TB kills about 1.5 million people each year worldwide
- Disease predominantly affects those in poorer nations
The Afrigen mRNA vaccine technology transfer hub in Cape Town.
Photographer: Dwayne Senior/BloombergThis article is for subscribers only.
A World Health Organization-backed group started work on developing an mRNA vaccine for tuberculosis, expanding on plans to develop local shots for the coronavirus.
Established in Cape Town last year, the mRNA hub is a response to a global outcry after developing nations struggled to secure pandemic inoculations even as rich countries stockpiled them. The work on a TB shot comes as it ultimately aims to develop inoculations to tackle neglected diseases that plague citizens of poorer countries.